Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the <it>APOC3</it>-related rs10892151 polymorphism
<p>Abstract</p> <p>Background</p> <p>The recently observed association between the APOC3-related rs10892151 polymorphism and serum triglyceride levels has prompted us the possibility to explore whether this genetic variant may play a major role in human immunodeficiency...
Saved in:
Main Authors: | Fernández-Sender Laura (Author), Rodríguez-Gallego Esther (Author), Beltrán-Debón Raúl (Author), Rull Anna (Author), Pardo-Reche Pedro (Author), Alonso-Villaverde Carlos (Author), Aragonès Gerard (Author), Camps Jordi (Author), Joven Jorge (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Deleterious Influence of Tenofovir-Based Therapies on the Progression of Atherosclerosis in HIV-Infected Patients
by: Gerard Aragonès, et al.
Published: (2012) -
Insulin Resistance, Inflammation, and Obesity: Role of Monocyte Chemoattractant Protein-1 (orCCL2) in the Regulation of Metabolism
by: Anna Rull, et al.
Published: (2010) -
40 Years of the APOC Partnership.
by: Jean-Baptist Roungou, et al.
Published: (2015) -
Ubiquitous Transgenic Overexpression of C-C Chemokine Ligand 2: A Model to Assess the Combined Effect of High Energy Intake and Continuous Low-Grade Inflammation
by: Esther Rodríguez-Gallego, et al.
Published: (2013) -
Managing the Fight against Onchocerciasis in Africa: APOC Experience.
by: Grace Fobi, et al.
Published: (2015)